Japan Drug Lobby Asserts Pricing Scheme Driving Drug Crisis

For the first time in the week starting May 16th, Japan’s three major pharmaceutical trade associations joined forces to call for changes to the government’s drug pricing structure in order to prevent missing out on new drug innovation and expansion. While American and European drug companies have long complained about Japan’s socialist medical system determining […]

Read the source article at Blogarama
2022-05-18 00:00:00